Sveriges mest populära poddar
CNBC's "Fast Money"
NyheterNäringsliv

A Chip Stock Gets Checked - Behind the Drop in Intel; and Gilead’s Remdesivir Gets the Green Light

44 min•22 oktober 2020

Intel shares plunged after the company reported weak results for its data center group. What’s next for the stock that’s been far underperforming the rest of the semi sector. And Gilead gets FDA approval for remdesivir. We break down the rest of the race for a COVID vaccine.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fler avsnitt av CNBC's "Fast Money"

Visa alla avsnitt av CNBC's "Fast Money"
Full Circle Moment for Markets … And Looking Ahead to the Biotech IPO Boom 6/18/26
•43 min
An Overhaul of Fed Operations… And Terry Duffy Steps Down as CME Group CEO 6/17/26
•44 min
SpaceX Impact On The Rest Of Techy… And Will the Crypto Winter Thaw? 6/16/26
•44 min
Proposed Iran Peace Deal Sparks Market Rally… And the Future of Perpetual Futures 6/15/26
•44 min
SpaceX IPO Soars in Trading Debut… And Looking Ahead to Warsh’s First Fed Meeting 6/12/26
•43 min
Stocks Surge On Potential End Of War… And Countdown to SpaceX Public Debut 6/11/26
•43 min
Markets Drop As Uncertainty Rises… And Oracle Reports Results 6/10/26
•44 min
A Decline in Chip Stocks Becomes Market Sell-off… Where Tech Sector is Heading 6/9/26
•44 min
Headlines From Apple’s WWDC… And Will Markets Recover from Recent Pullback? 6/8/26
•43 min
Stocks Tumble To Wrap Up Week… And Tim Cook’s Last Developer’s Conference 6/5/26
•43 min

CNBC's "Fast Money" med CNBC finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.